Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference

• Published in: Transplantation Vol. 104; no. 6; pp. 1125 - 1130
• Main Authors: Sapisochin, Gonzalo, Javle, Milind, Lerut, Jan, Ohtsuka, Masayuki, Ghobrial, Mark, Hibi, Taizo, Kwan, Nancy Man, Heimbach, Julie
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health, Inc. All rights reserved 01-06-2020; Copyright Wolters Kluwer Health, Inc. All rights reserved
• Subjects: Bile Duct Neoplasms - mortality; Bile Duct Neoplasms - therapy; Chemoradiotherapy, Adjuvant - methods; Chemoradiotherapy, Adjuvant - standards; Cholangiocarcinoma - mortality; Cholangiocarcinoma - therapy; Consensus; Humans; Liver Transplantation - standards; Medical Oncology - standards; Neoadjuvant Therapy - methods; Neoadjuvant Therapy - standards; Practice Guidelines as Topic; Preoperative Care - methods; Preoperative Care - standards; Survival Rate; Treatment Outcome
• ISSN: 0041-1337; 1534-6080
• DOI: 10.1097/TP.0000000000003212

Liver transplantation for cholangiocarcinoma has been an absolute contraindication worldwide due to poor results. However, in recent years and thanks to improvements of patient management and treatments of this cancer, this indication has been revisited. This consensus paper, approved by the International Liver Transplant Society, aims to provide a collection of expert opinions, consensus, and best practices surrounding liver transplantation for cholangiocarcinoma.